🎁 Black Friday: up to 50% off of annual plans
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
13.66
-0.50 (-3.53%)
At close: Nov 20, 2026, 4:00 PM EST
13.70
+0.04 (0.29%)
After-hours: Nov 20, 2026, 7:30 PM EST

Mineralys Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,2102,872613354--
Market Cap Growth
-63.71%368.78%73.31%---
Enterprise Value
6832,278349100--
Last Close Price
13.6636.2912.318.60--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.404.443.201.47--
P/TBV Ratio
2.404.443.201.47--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.20-----
Net Debt / Equity Ratio
-1.04-1.01-1.04-0.98-1.03-1.75
Net Debt / EBITDA Ratio
1.353.851.03---
Net Debt / FCF Ratio
3.444.611.192.913.770.73
Quick Ratio
11.7743.4513.5322.5713.652.10
Current Ratio
11.8343.7614.0223.7713.982.20
Return on Equity (ROE)
-68.50%-36.91%-82.24%-41.38%-53.00%-1568.96%
Return on Assets (ROA)
-60.16%-35.65%-77.72%-39.28%-47.46%-307.80%
Return on Capital Employed (ROCE)
-67.50%-26.40%-100.60%-35.10%-29.60%-308.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-32.07%-5.38%-29.02%-20.34%--
FCF Yield
-12.65%-4.96%-27.16%-22.96%--
Buyback Yield / Dilution
-41.14%-39.38%-34.13%-600.33%-3.67%-7.64%
SEC Filings: 10-K · 10-Q